MAGENTA THERAPEUTICS, INC

Organization

BOSTON, MA, US

Ticker Symbols

NASDAQ:MGTA

PHARMACEUTICAL PREPARATIONS
Business Address
50 HAMPSHIRE STREET CAMBRIDGE MA 02139 857-201-2700
Mailing Address
50 HAMPSHIRE STREET CAMBRIDGE MA 02139
State Location
MA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Anti-CD117 antibodies and conjugates
- Patent number 11,572,411
- Issue date Feb 7, 2023
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosing regimens for the mobilization of hematopoietic stem and prog...
- Patent number 11,260,079
- Issue date Mar 1, 2022
- Magenta Therapeutics, Inc.
- Dwight Morrow
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Linkers for antibody-drug conjugates and related compounds, composi...
- Patent number 11,229,711
- Issue date Jan 25, 2022
- Magenta Therapeutics, Inc.
- David Y. Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl hydrocarbon receptor antagonists and uses thereof
- Patent number 10,919,900
- Issue date Feb 16, 2021
- Magenta Therapeutics Inc.
- Arthur Glenn Romero
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Compositions and methods for the depletion of CD117+ cells
- Patent number 10,899,843
- Issue date Jan 26, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for the depletion of CD117+ cells
- Patent number 10,882,915
- Issue date Jan 5, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified antibodies and related compounds, compositions, and method...
- Patent number 10,781,259
- Issue date Sep 22, 2020
- Magenta Therapeutics, Inc.
- David Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the depletion of cells
- Patent number 10,624,973
- Issue date Apr 21, 2020
- Magenta Therapeutics, Inc.
- Andrew Nixon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the depletion of CD137+ cells
- Patent number 10,576,161
- Issue date Mar 3, 2020
- Magenta Therapeutics, Inc.
- Adam Hartigan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl hydrocarbon receptor antagonists and uses thereof
- Patent number 10,457,683
- Issue date Oct 29, 2019
- Magenta Therapeutics Inc.
- Arthur Glenn Romero
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for the depletion of CD137+ cells
- Patent number 10,434,185
- Issue date Oct 8, 2019
- Magenta Therapeutics, Inc.
- Adam Hartigan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aryl hydrocarbon receptor antagonists and uses thereof
- Patent number 10,351,572
- Issue date Jul 16, 2019
- Magenta Therapeutics Inc.
- Arthur Glenn Romero
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the depletion of CD117+ cells
- Patent number 10,111,966
- Issue date Oct 30, 2018
- Magenta Therapeutics, Inc.
- Andrew Nixon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dosing regimens for the mobilization of hematopoietic stem cells
- Patent number 10,058,573
- Issue date Aug 28, 2018
- Magenta Therapeutics, Inc.
- Dwight Morrow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
- Publication number 20240207428
- Publication date Jun 27, 2024
- Magenta Therapeutics, Inc.
- Andrew NIXON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF
- Publication number 20240075157
- Publication date Mar 7, 2024
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES
- Publication number 20230414565
- Publication date Dec 28, 2023
- Magenta Therapeutics, Inc.
- John C. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR ALLOGENEIC TRANSPLANTATION
- Publication number 20230390412
- Publication date Dec 7, 2023
- Magenta Therapeutics, Inc.
- Geoffrey O. Gillard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PRO...
- Publication number 20230330185
- Publication date Oct 19, 2023
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
T-CELL BISPECIFIC BINDING PROTEINS
- Publication number 20230183344
- Publication date Jun 15, 2023
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS
- Publication number 20230130646
- Publication date Apr 27, 2023
- Magenta Therapeutics, Inc.
- Dwight Morrow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, C...
- Publication number 20230109312
- Publication date Apr 6, 2023
- Magenta Therapeutics, Inc.
- David Y. Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROG...
- Publication number 20220401481
- Publication date Dec 22, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES
- Publication number 20220273811
- Publication date Sep 1, 2022
- Magenta Therapeutics, Inc.
- Geoffrey O. Gillard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20220267441
- Publication date Aug 25, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
T-CELL DEPLETING THERAPIES
- Publication number 20220249683
- Publication date Aug 11, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTHRACYCLINE ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20220226493
- Publication date Jul 21, 2022
- Magenta Therapeutics, Inc.
- Charlotte Fenton McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD117 ANTIBODY-DRUG CONJUGATES AND USES THEREOF
- Publication number 20220175944
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Charlotte F. McDonagh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD117 ANTIBODIES AND USES THEREOF
- Publication number 20220177578
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-CD45 Antibody Drug Conjugates and Uses Thereof
- Publication number 20220175951
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD117 ANTIBODIES AND USES THEREOF
- Publication number 20220177575
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD117 ANTIBODY DRUG CONJUGATES AND USES THEREOF
- Publication number 20220177577
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Charlotte Fenton McDonagh
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CONDITIONING METHODS FOR GENE THERAPY
- Publication number 20220175946
- Publication date Jun 9, 2022
- Magenta Therapeutics, Inc.
- Anthony BOITANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROG...
- Publication number 20220096559
- Publication date Mar 31, 2022
- Magenta Therapeutics, Inc.
- Dwight Morrow
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF AN ANTI-CD45 ANTIBODY DRUG CONJUGATE (ADC) IN CELL THERAPY
- Publication number 20220062339
- Publication date Mar 3, 2022
- Magenta Therapeutics, Inc.
- Michael Cooke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR HEMATOPOIETIC STEM AND PROGENITOR CELL TRANSPLANT THERAPY
- Publication number 20210379113
- Publication date Dec 9, 2021
- Magenta Therapeutics Inc.
- Glen RAFFEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS
- Publication number 20210379033
- Publication date Dec 9, 2021
- Magenta Therapeutics Inc.
- Anthony BOITANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
- Publication number 20210379195
- Publication date Dec 9, 2021
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20210371524
- Publication date Dec 2, 2021
- Magenta Therapeutics, Inc.
- Rahul Palchaudhuri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS
- Publication number 20210369854
- Publication date Dec 2, 2021
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-CD5 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL TH...
- Publication number 20210355230
- Publication date Nov 18, 2021
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS
- Publication number 20210317228
- Publication date Oct 14, 2021
- Magenta Therapeutics, Inc.
- Bradley R. Pearse
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCS)
- Publication number 20210283267
- Publication date Sep 16, 2021
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN ANTI-CD2 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL...
- Publication number 20210260212
- Publication date Aug 26, 2021
- Magenta Therapeutics, Inc.
- Anthony Boitano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
97270788 - #THECOLOROFCURE
- Serial number 97270788
- Filing date Feb 16, 2022
- Magenta Therapeutics, Inc.
- 35 - Advertising
Information Trademark
88052601 - #THECOLOROFCURE
- Serial number 88052601
- Filing date Jul 25, 2018
- Magenta Therapeutics, Inc.
- 35 - Advertising
Information Trademark
87082093 - MAGENTA THERAPEUTICS
- Serial number 87082093
- Registration number 5287486
- Filing date Jun 23, 2016
- MAGENTA THERAPEUTICS, INC.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
86892193 - MAGENTA THERAPEUTICS
- Serial number 86892193
- Registration number 5277250
- Filing date Jan 30, 2016
- HSCTCo Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto

MAGENTA THERAPEUTICS, INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Anti-CD117 antibodies and conjugates

Dosing regimens for the mobilization of hematopoietic stem and prog...

Linkers for antibody-drug conjugates and related compounds, composi...

Aryl hydrocarbon receptor antagonists and uses thereof

Compositions and methods for the depletion of CD117+ cells

Compositions and methods for the depletion of CD117+ cells

Modified antibodies and related compounds, compositions, and method...

Methods for the depletion of cells

Compositions and methods for the depletion of CD137+ cells

Aryl hydrocarbon receptor antagonists and uses thereof

Compositions and methods for the depletion of CD137+ cells

Aryl hydrocarbon receptor antagonists and uses thereof

Methods for the depletion of CD117+ cells

Dosing regimens for the mobilization of hematopoietic stem cells

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS

FC SILENCED ANTIBODY DRUG CONJUGATES (ADCS) AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING HEMATOLOGICAL MALIGNANCIES

COMPOSITIONS AND METHODS FOR ALLOGENEIC TRANSPLANTATION

METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PRO...

T-CELL BISPECIFIC BINDING PROTEINS

DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM CELLS

NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, C...

DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROG...

METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

T-CELL DEPLETING THERAPIES

ANTHRACYCLINE ANTIBODY-DRUG CONJUGATES AND USES THEREOF

ANTI-CD117 ANTIBODY-DRUG CONJUGATES AND USES THEREOF

ANTI-CD117 ANTIBODIES AND USES THEREOF

Anti-CD45 Antibody Drug Conjugates and Uses Thereof

ANTI-CD117 ANTIBODIES AND USES THEREOF

ANTI-CD117 ANTIBODY DRUG CONJUGATES AND USES THEREOF

CONDITIONING METHODS FOR GENE THERAPY

DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROG...

USE OF AN ANTI-CD45 ANTIBODY DRUG CONJUGATE (ADC) IN CELL THERAPY

METHODS FOR HEMATOPOIETIC STEM AND PROGENITOR CELL TRANSPLANT THERAPY

METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS

METHODS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS

USE OF ANTI-CD5 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL TH...

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

THERAPEUTIC METHODS USING ANTIBODY DRUG CONJUGATES (ADCS)

USE OF AN ANTI-CD2 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL...

Trademarklast 30 trademarks

97270788 - #THECOLOROFCURE

88052601 - #THECOLOROFCURE

87082093 - MAGENTA THERAPEUTICS

86892193 - MAGENTA THERAPEUTICS